somatic cell nuclear transfer

somatic cell nuclear transfer
Name	Somatic cell nuclear transfer
Purpose	Cloning, research, regenerative medicine
Field	Genetics, Developmental biology

somatic cell nuclear transfer Somatic cell nuclear transfer is a laboratory technique in developmental biology and Genetics for generating embryos by replacing the nucleus of an oocyte with the nucleus of a differentiated somatic cell. It has been used across systems from Dolly (sheep) and farm animals to model organisms such as Mus musculus and Xenopus laevis, and has driven debates in settings ranging from the United Kingdom and United States to Japan and Australia. Proponents and critics have engaged in public discussion in venues including the United Nations and national legislatures such as the United States Congress and the European Parliament.

Introduction

Somatic cell nuclear transfer is distinct from techniques like in vitro fertilisation and involves cytoplasmic reprogramming of a somatic nucleus within an enucleated oocyte to produce a zygote-like entity. Laboratory groups at institutions such as the Roslin Institute, Kyoto University, Massachusetts Institute of Technology, and the National Institutes of Health have published pivotal demonstrations, while regulatory bodies including the Food and Drug Administration and the Human Fertilisation and Embryology Authority have overseen related policy. High-profile figures and teams—such as researchers associated with Ian Wilmut, Keith Campbell, Shoukhrat Mitalipov, and organizations like Cleveland Clinic—have shaped public and scientific perceptions.

Procedure and Techniques

The standard workflow begins with oocyte retrieval comparable to protocols used in Johns Hopkins Hospital and clinics modeled on techniques from groups at Harvard Medical School and University of Cambridge. An oocyte from a donor is enucleated, often using micromanipulation systems developed by companies and labs linked to Zeiss, Nikon Corporation, and engineering groups at Stanford University. A somatic nucleus—sourced from tissues characterized in studies at Salk Institute, Max Planck Society, and Cold Spring Harbor Laboratory—is transferred into the enucleated oocyte. Activation can follow chemical or electrical cues tested originally by authors connected to University of Edinburgh and adapted by teams at University of California, San Francisco and Shanghai Jiao Tong University. Epigenetic reprogramming strategies draw on knowledge from researchers affiliated with National Institute of Child Health and Human Development, Broad Institute, and the European Molecular Biology Laboratory, including use of histone modification modulators and factors investigated at Rockefeller University and Imperial College London. Variants include interspecies nuclear transfer explored by labs at University of Tokyo, University of Melbourne, and University of Pennsylvania.

Applications and Uses

Applications span agricultural biotechnology championed by firms and centers such as Monsanto (now Bayer) collaborations, biomedical models developed at Jackson Laboratory and translational research at Mayo Clinic, regenerative medicine initiatives in consortiums like Cellular Dynamics International partnerships, and conservation efforts promoted by organizations such as World Wide Fund for Nature and the Smithsonian Institution. Therapeutic cloning research has been pursued by groups at University of California, Los Angeles, Seoul National University, and Peking University to derive patient-specific pluripotent cells for disease models of conditions studied at institutions like Johns Hopkins University School of Medicine, University of Oxford, and Karolinska Institutet. Livestock cloning projects have been undertaken at Iowa State University, University of Nottingham, and Shanghai Academy of Agricultural Sciences for traits traced in breeding programs linked to United States Department of Agriculture. High-profile demonstrations—such as cloning of companion animals by firms related to ViaGen Pets and academic spinouts connected to Reproductive Biology Associates—have influenced commercial avenues and veterinary medicine debates.

Ethical, Legal, and Social Issues

Ethical discourse has been framed by commentators from institutions including University of Oxford, Harvard University, and Georgetown University and debated in forums from the Council of Europe to national courts like the Supreme Court of the United States. Concerns about identity, personhood, and welfare have been raised by bioethicists associated with The Hastings Center, Kennedy Institute of Ethics, and the Nuffield Council on Bioethics. Legislative responses range from prohibitions and moratoria in jurisdictions such as Germany and Italy to regulated frameworks in United Kingdom and South Korea. Advocacy groups including Human Rights Watch, Greenpeace, and faith-based organizations like the Vatican have weighed in alongside industry stakeholders such as BIO (Biotechnology Innovation Organization) and professional societies like the International Society for Stem Cell Research.

Scientific Challenges and Limitations

Efficiency and developmental competence remain major hurdles documented by laboratories at University of California, Davis, University of Glasgow, and McGill University. Problems include incomplete epigenetic resetting studied by teams at University College London, genomic instability reported by researchers at Fred Hutchinson Cancer Center, and mitochondrial-nuclear incompatibilities described in collaborations involving European Research Council grants. Immunological and tumorigenic risks have been examined in preclinical programs at NIH Clinical Center and translational units within Cleveland Clinic. Reproducibility concerns have prompted meta-analyses from consortia such as the Cochrane Collaboration and multicenter efforts coordinated by networks including the Wellcome Trust and the Gates Foundation.

History and Key Developments

Early nuclear transfer experiments were conducted by pioneers like Hans Spemann and later expanded by teams at T.W. Nuffield Laboratory-era institutions, with landmark amphibian work by groups at Institute of Cancer Research and University of Cambridge in the 20th century. Mammalian cloning breakthroughs culminated in the announcement of Dolly (sheep) by the Roslin Institute team, led by figures sometimes linked to Ian Wilmut and Keith Campbell, which catalyzed subsequent milestones at Seoul National University (cloned dogs), University of Pennsylvania (cloned horses), and laboratories affiliated with Shoukhrat Mitalipov (non-human primates). Policy and public response evolved through incidents considered by bodies such as the Royal Society, European Commission, and national advisory committees including the Council on Bioethics (Ireland). More recent advances reported by groups at Salk Institute, Riken, and MRC Laboratory of Molecular Biology continue to refine protocols and address earlier limitations.

Category:Cloning